ID microgel cards in detection of IgA deficiency in patients with gastrointestinal tumors

Vesna Libek ,
Vesna Libek
Ljiljana Sofronic-Milosavljevic ,
Ljiljana Sofronic-Milosavljevic
Andrijana Kulic ,
Andrijana Kulic
Ana Strugar ,
Ana Strugar
Ivana Simic ,
Ivana Simic
Jelena Djurdjevic ,
Jelena Djurdjevic
Ivana Gojkovic ,
Ivana Gojkovic
Milena Milicev
Milena Milicev

Published: 01.12.2012.

Biochemistry

Volume 29, Issue 4 (2013)

pp. 953-958;

https://doi.org/10.5937/matmed1304953l

Abstract

Immunoglobulin A deficiency (IgAD) is the most common form of primary immunodeficiency.

IgAD is characterized by apscence or very low level of serum IgA (<0.7 mg/dL) and normal serum ranges of IgG and IgM. Pathogenesis of IgAD and its molecular and genetic basis is important, knowing that this immunodeficiency is related with epithelial malignancies such as respiratory and gastrointestinal tumors. Aim of this study was to investigate IgAD in patients with gastrointestinal malignancies, as well as to determine potential relation between IgAD and certan type of tumor. The research included 60 patients with confirmed gastrointestinal tumors of various types. For every patient qualitatively were tested levels of serum IgA and anti IgA atibodies, using ID microgel cards (Particle Gel Immuno Assay methods). Levels of serum IgA were also quantitavely tested in reference laboratory. Using Particle Gel Immunoassay method, there was no evidence for decrease of serum IgA or presence of anti-IgA antibodies in our group of patinets. This result was confirmed with quantitative laboratory investigation. This study shows no significant relation between IgAD and gastrointestinal tumors, which is in accordance with actual litarture.

There have only been registered sporadic cases of carcinoma in these patients, which implies that the research should include a larger number of patients.

Also, more detail cognition of molecular and genetic mechanism of IgAD would help in understanding oncogenic effect of this immunodeficiency.

Keywords

References

1.
Clark JA, Callicoat PA, Brenner NA, Bradley CA, DM S. Selective IgA deficiency in blood donors.
2.
Am J Clin Pathol. 1983;80(2):210–3.
3.
Sandler SG, Eckrich R, Malamut D, Mallory D. Hemagglutination assays for the diagnosis and prevention of IgA anaphylactic transfusion reactions. Blood. 1994;15;84(6):2031-5.
4.
Sanz C, Freire C, Ordinas A, Pereira A. An enzyme-linked immunosorbent assay applicable to screen blood donors for IgA deficiency. Haematologica. 1999;84(10):887–90.
5.
IgA Deficiency: Immunodeficiency Disorders: Merck Manual Professional.
6.
Burrows PD, Cooper MD. IgA deficiency. Adv Immunol. 1997;65:245–76.
7.
Cunningham-Rundles C. Physiology of IgA and IgA deficiency. J Clin Immunol. 2001;Sep;21(5):303-9.
8.
The complex genetics of common variable immunodeficiency. J Investig Med. 2004;52(2):90–103.
9.
Castigli E, Geha RS. Molecular basis of common variable immunodeficiency. J Allergy Clin Immunol. 2006;117(4):740–6.
10.
BU M, PA P. Cancer in children with primary or secondary immunodeficiencies. J Pediatr. 1996;126:1–10.
11.
Sandler SG, Mallory D, Malamut D, Eckrich R. IgA anaphylactic transfusion reactions. Transfus Med Rev. 1995;9(1):1–8.
12.
Salama A, Temmesfeld B, Hippenstiel S, Kalus U, Suttorp N, Kiesewetter H. A new strategy for the prevention of IgA anaphylactic transfusion reactions. Transfusion. 2004;44(4):509–11.
13.
Ahrens N, Bombard S, Pan Q, Hammarstrom L, Kiesewetter H, Salama A. A particle gel mmuno-assay (PaGIA) for detection IgA and antibodies to IgA.
14.
Koskinen S. Long-term follow-up of health in blood donors with primary selective IgA deficiency. J Clin Immunol. 1996;16(3):165–70.
15.
Cunningham-Rundles C, Pudifin DJ, Armstrong D, Good RA. Selective IgA deficiency and neoplasia. Vox Sang. 1980;38(2):61–7.
16.
Mellemkjaer L, Hammarstrom L, Andersen V, Yuen J, Heilmann C, Barington T, et al. Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish study. Clin Exp Immunol. 2002;130(3):495–500.

Citation

Copyright

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Partners